How Charles River Laboratories Pays
Charles River's B0 to B12 normalized ladder from Animal Technician I to Corporate Vice President, priced across 23 markets alongside the 2026 Long-Term Incentive Plan's RSUs, PSUs and options, a $15.44M FY2025 CEO package at 251:1, and 151 certified H-1B filings since FY2021.
Band Hierarchy
Charles River publishes job-family ladders, not a grade catalogue. Animal Caretaker I to IV, Animal Technician I to IV, Research Scientist I to VII, Study Director, Associate Scientific Director, Director, Senior Director, General Manager, Executive Director and Corporate Vice President are all visible in careers material; B0 to B10 is a research normalization laid over them so that markets can be compared. Above B10 the ladder becomes an SEC disclosure rather than a career level.
Operations and technician ladder — B0 through B2
Scientific ladder — B3 through B5
Expert and management fork — B6 through B7
Leadership ladder — B8 through B10
Disclosed executive layer
Track divergence
Hierarchy qualifications and legacy structures
- No official band numbers were found in any reviewed filing, careers page or job posting. B0 to B10 is an analytical catalogue built so that a Tranent scientist and a Reno scientist can be compared, and it should never be quoted back to a recruiter as a Charles River grade.
- A numeric title suffix is a job-family level, not a company-wide grade. Research Scientist I to VII, Animal Technician I to IV and Biomanufacturing Technician I to III each number independently, so a III in one family is not a III in another.
- The Roman numeral does not mean entry level. Several Research Scientist I postings asked for around six years of experience, which is why that title is mapped to B4 rather than to the bottom of the ladder.
- The crosswalk is most reliable in scientific and laboratory-operations families, where Charles River posts explicit United States ranges, and least reliable in sales, business development and digital roles, where variable pay and quota structures are entirely unpublished.
- Charles River has acquired and divested repeatedly, but no public source documents an enterprise-wide legacy grade conversion or harmonisation matrix, so acquired-site title structures cannot be reconciled here.
- The officer and director tiers are corporate designations, not the top of an employee ladder, and are carried in the executive section rather than in the band table.
Peer-level mapping
| Band | Archetype | Peer mapping | Caveat |
|---|---|---|---|
| B0 | Intern / Trainee | Contract-research and life-science tools intern and student placement programmes | Charles River publishes no grade code, so every peer row here is a scope comparison rather than a company crosswalk.Midpoint of a $36,000 to $48,000 planning range modelled from entry-level postings; no direct Charles River intern rate was published. |
| B1 | Assistant / Technician I | Laboratory assistant and technician I roles across the contract-research sector | Several of these roles are hourly and non-exempt in the United States, so an annualised figure overstates a part-year or part-time hire.Midpoint of $39,000 to $55,000, anchored on an Animal Research Technician I posting at $22.52 an hour, a Sample Coordinator I at $42,000 and an Archives Associate I at $21 to $23 an hour. |
| B2 | Technician II / Analyst I | Research analyst I and technician II roles at diagnostics and CRO peers | Numeric suffixes are job-family levels inside a role, not a company-wide grade, so a Technician II in one family need not match a II in another.Midpoint of $45,000 to $68,000, anchored on a Research Analyst I posting at $52,000 plus United States analyst and technical-trainer records. |
| B3 | Associate Scientist / Research Associate | Research associate and associate scientist rungs on a CRO scientific delivery ladder | The Associate Scientist and Research Associate titles overlap in Charles River postings and cannot be ordered reliably from public evidence.Midpoint of $55,000 to $82,000, anchored on an Associate Scientist II posting at $60,000 to $75,000 and a Senior Associate Scientist at $80,000. |
| B4 | Scientist / Research Scientist I | Scientist I and II rungs at contract-research and life-science tools peers | The Roman numeral is misleading here: several Research Scientist I postings asked for six years of experience, so this is not an entry band.Midpoint of $78,000 to $110,000, anchored on Research Scientist I postings at $87,000 to $93,000 in Ashland, from $95,000 in Reno and $100,000 to $110,000 in Shrewsbury. |
| B5 | Senior Scientist / Study Director | Senior scientist and study director rungs across the safety-assessment sector | Study Director is a regulated GLP accountability, so its market rate is set by study ownership rather than by years of service.Midpoint of $95,000 to $132,000, anchored on a Senior Scientist posting in Wayne, Pennsylvania at $123,000 to $130,000 plus United States salary datasets. |
| B6 | Principal Scientist / Manager | Principal scientist and laboratory or operations manager rungs at CRO peers | This is where the scientific and people-leadership paths separate, and Charles River publishes no salary difference between the two.Midpoint of $115,000 to $150,000 from cross-source planning evidence; no direct Charles River posting at this band disclosed a range. |
| B7 | Associate Director / Senior Manager | Associate director and senior manager rungs across CRO and diagnostics peers | The Associate Scientific Director title sits on the expert path while Associate Director is usually a people-leadership role at the same band.Midpoint of $140,000 to $180,000, anchored on an Associate Scientific Director posting in Reno at $145,000 to $150,000 plus observed associate-director records. |
| B8 | Director | Functional and business-unit director rungs at contract-research peers | Commercial directors carry sales incentives that are not published, so a business-development director package can sit above this base band.Midpoint of $150,000 to $205,000, anchored on a Director, Equity and Executive Compensation posting at $150,000 to $185,000 plus salary datasets. |
| B9 | Senior Director / General Manager / Executive Director | Senior director, site general manager and executive director rungs at CRO peers | A site general manager owns a profit and loss statement while a global functional head does not, and the public evidence cannot separate the two.Midpoint of $190,000 to $260,000, anchored on a Senior Director, Global Quality posting at $200,000 to $240,000; the incentive target for this band is not public. |
| B10 | Vice President / Corporate Vice President | Corporate vice president and regional leadership tiers at listed CRO peers | This is the last band below the SEC-disclosed population, so it is the widest and least evidenced row in the table.Midpoint of a wide $230,000 to $400,000 planning range. No Charles River vice-president salary or bonus schedule is public; the only disclosure attaching to the band is a 1x base stock-ownership guideline. |
Critical evidence warning
Charles River does not publish salary bands, range minimums, midpoints or maximums for any employee population, and it publishes no bonus target and no equity grant schedule below the officer tier. That makes this ladder unusually asymmetric: the United States rungs from Animal Technician I to Senior Director are anchored on real company job postings with disclosed pay ranges, while every non-United States figure is a market-normalised planning estimate derived from the Wilmington anchor and a single city factor. The company's own pay-ratio disclosure shows how thin the international evidence is, with 68 employees in India, 42 in South Korea, 41 in Singapore, 18 in Australia and two in Israel before the de minimis exclusion. Use the United States rows as an orientation and the international rows as a planning envelope, not as a quote of a Charles River scale.
Compensation by Band — Wilmington, MA
Low / median / high annual values at 1.00× base and 1.00× total-compensation factors versus Wilmington, MA. Total equals base plus bonus plus annualized equity.
| Band | Title | Base | Variable | Total TC | Equity |
|---|---|---|---|---|---|
| B0 | Intern / Trainee 0–1 years · modeled | $36K – $48K | — | $42K $36K – $48K | — |
| B1 | Assistant / Technician I 0–2 years · verified | $40K – $54K | — | $47K $40K – $54K | — |
| B2 | Technician II / Analyst I 1–3 years · verified | $48K – $65K | — | $57K $48K – $65K | — |
| B3 | Associate Scientist / Research Associate 2–5 years · verified | $58K – $79K | — | $69K $58K – $79K | — |
| B4 | Scientist / Research Scientist I 4–7 years · verified | $80K – $108K | — | $94K $80K – $108K | — |
| B5 | Senior Scientist / Study Director 6–10 years · verified | $96K – $131K | — | $114K $96K – $131K | — |
| B6 | Principal Scientist / Manager 8–12 years · modeled | $113K – $152K | — | $133K $113K – $152K | — |
| B7 | Associate Director / Senior Manager 10–15 years · verified | $136K – $184K | — | $160K $136K – $184K | — |
| B8 | Director 10–16 years · verified | $151K – $204K | — | $178K $151K – $204K | — |
| B9 | Senior Director / General Manager / Executive Director 12–18 years · verified | $191K – $259K | — | $225K $191K – $259K | — |
| B10 | Vice President / Corporate Vice President 15–22 years · modeled | $268K – $362K | — | $315K $268K – $362K | — |
Total Compensation Range by Band
Total compensation in Wilmington, MA across the employee bands. Ranges are planning envelopes around the median, not offer bands.
Global Footprint & Pay Arbitrage
Charles River operated more than 120 sites in more than 20 countries at the end of FY2025, with roughly 59 percent of employees in North America, 32 percent in Europe, 7 percent in Asia and 3 percent elsewhere. Wilmington, Massachusetts is the pay anchor and every other market is a single calibration factor against it.
Office and market catalogue — calibration factors versus Wilmington, MA
| Location | Likely office profile | Presence | Base | TC |
|---|---|---|---|---|
Wilmington, MA United States · USD | Global headquarters, corporate functions and the executive population disclosed in the proxy | Official location directory | 1.00× | 1.00× |
Shrewsbury, MA United States · USD | Massachusetts laboratory and Discovery and Safety Assessment site | Official location directory | 0.97× | 0.97× |
Reno, NV United States · USD | Discovery and Safety Assessment site with published scientist and director postings | Official location directory | 0.90× | 0.90× |
Mattawan, MI United States · USD | Largest single safety-assessment campus in the visa record and the lowest-cost major United States market here | Official location directory | 0.78× | 0.78× |
San Diego, CA United States · USD | Scientific and commercial presence in a high-cost West Coast biotech cluster | Official location directory | 1.08× | 1.08× |
Montréal / Senneville Canada · CAD | Major Canadian scientific site with direct Study Director and associate-level records | Official location directory | 0.69× | 0.69× |
Tranent / Edinburgh United Kingdom · GBP | Largest disclosed United Kingdom scientific site and the European scientist anchor | Official location directory | 0.50× | 0.50× |
Cambridge United Kingdom · GBP | Scientific and commercial presence carrying a Cambridge cluster premium over Tranent | Official location directory | 0.58× | 0.58× |
Lyon France · EUR | Scientific and commercial sites in the one European country with a named equity sub-plan | Official location directory | 0.58× | 0.58× |
Cologne Germany · EUR | Scientific and commercial presence modelled from European anchors | Official location directory | 0.63× | 0.63× |
Leiden Netherlands · EUR | Scientific and commercial presence modelled from European anchors | Official location directory | 0.64× | 0.64× |
Dublin / Ballina Ireland · EUR | Scientific and corporate presence; the highest-factor euro market in this table | Official location directory | 0.65× | 0.65× |
Gödöllő / Budapest Hungary · HUF | Scientific and support operations; the lowest-cost European market in this table | Official location directory | 0.35× | 0.35× |
Bangalore India · INR | Small commercial and support footprint; India held 68 employees in the pay-ratio population | Official location directory | 0.16× | 0.16× |
Mumbai India · INR | Commercial and support presence with a small metropolitan premium over Bangalore | Official location directory | 0.17× | 0.17× |
Hyderabad India · INR | Commercial and support presence; the lowest factor of the three Indian markets | Official location directory | 0.15× | 0.15× |
Melbourne Australia · AUD | Commercial and laboratory presence; Australia held 18 employees in the pay-ratio population | Official location directory | 0.70× | 0.70× |
Sydney Australia · AUD | Commercial presence carrying a Sydney uplift over the sparse Melbourne evidence | Official location directory | 0.75× | 0.75× |
Tokyo / Yokohama Japan · JPY | Commercial and scientific presence with no company-specific salary dataset located | Official location directory | 0.62× | 0.62× |
Shanghai China · CNY | Commercial and scientific presence with no company-specific salary dataset located | Official location directory | 0.40× | 0.40× |
Seoul South Korea · KRW | Commercial presence; Korea held 42 employees in the pay-ratio population | Official location directory | 0.48× | 0.48× |
Singapore Singapore · SGD | Regional commercial hub; Singapore held 41 employees in the pay-ratio population | Official location directory | 0.64× | 0.64× |
Jerusalem Israel · ILS | Smallest disclosed footprint in this table; two employees appeared in the pay-ratio population | Official location directory | 0.70× | 0.70× |
Charles River publishes a location directory but not city-level headcount, so this catalogue cannot rank offices by size. The only geographic population figures in the filings are the regional workforce split and the small per-country counts disclosed in the pay-ratio de minimis analysis.
Wilmington, MA anchor medians — the basis of every modeled cell
| Band | Base | Stock | Bonus | Total |
|---|---|---|---|---|
| B1 | $47K | $0 | $0 | $47K |
| B2 | $57K | $0 | $0 | $57K |
| B3 | $69K | $0 | $0 | $69K |
| B4 | $94K | $0 | $0 | $94K |
| B5 | $114K | $0 | $0 | $114K |
| B7 | $160K | $0 | $0 | $160K |
| B8 | $178K | $0 | $0 | $178K |
| B9 | $225K | $0 | $0 | $225K |
- Wilmington is the anchor because it is the global headquarters and the only market where company job postings cover the ladder from technician to senior director. Its band medians are the midpoints of those posted ranges.
- Shrewsbury at 0.97 and Reno at 0.90 are calibrated from direct company postings in those cities, which is why a Research Scientist I is posted at $100,000 to $110,000 in Shrewsbury and from $95,000 in Reno.
- Mattawan, Michigan at 0.78 is the largest safety-assessment campus in the visa record and the clearest evidence that site choice moves pay more than title does: its captured H-1B median is $76,594 with 87 percent of records below $100,000.
- Tranent near Edinburgh at 0.50 carries the European scientist anchor, resting on Glassdoor United Kingdom records of £25,000 to £31,000 for a Scientist and £34,000 to £40,000 for a Senior Scientist.
- Bangalore at 0.16 is the lowest factor in the table and the least evidenced. Charles River disclosed only 68 employees in India in the pay-ratio population, and the sole company-specific Indian salary observation is a two-profile reported average of ₹18.2 lakh.
- Segment headcount was roughly 11,760 in Discovery and Safety Assessment, 4,140 in Research Models and Services and 2,600 in Manufacturing Solutions, so the scientific bands carry most of the workforce.
Model rules
- Every non-Wilmington cell is the Wilmington median multiplied by that city's calibration factor and then by the 26 August 2026 foreign-exchange snapshot.
- Base and total factors are identical for every market and flat across the ladder. Charles River is a site-based laboratory network rather than an offshore delivery model, so the bundle evidences no level-dependent compression to interpolate and no top-of-ladder factor is applied.
- Total compensation equals base pay in every band. No employee bonus target and no employee grant size is publicly disclosed, so the report shows a real zero rather than a modelled incentive.
- The bundle's own total column applied a notional employer-cost uplift rising from 1.06x at B0 to 1.8x at B10. That is employer cost, not pay, and it has been removed so base plus bonus plus equity reconciles to total.
- The officer and chief executive rows are excluded from the band table entirely. Their pay is a global peer-market figure that is identical in every city, and multiplying it by a 0.16 India factor or a 0.50 United Kingdom factor would invent a local executive scale that does not exist.
- A cell marked modeled is a planning envelope. Only the United States rows anchored on posted company ranges, and the four Glassdoor-anchored international titles, rest on a direct observation.
Variable Pay & Annual Cash Incentive
Charles River discloses its executive cash incentive plan in unusual detail and discloses nothing at all about employee bonus targets. The Executive Incentive Compensation Plan is a single annual cash plan, scored half on global company results and half on business-segment results, and it paid 139 percent of target for 2025.
| Band | Target | Mechanism | Recent payout |
|---|---|---|---|
B0–B10 Every employee band below the officer tier | Not publicly disclosed | The proxy states that employees on short-term incentive plans shared the same 2025 metric architecture as executives, but no target percentage, eligibility threshold or band schedule is published anywhere in the reviewed evidence. | Not publicly disclosed |
SVP Senior Vice President | 50% of base | Annual Executive Incentive Compensation Plan on global revenue and operating income plus segment revenue and operating income. | 139% of target for 2025; Michael Knell's $250,000 target paid $347,500 |
EVP Corporate Executive Vice President | 70% of base | Annual Executive Incentive Compensation Plan on the same 50 percent global and 50 percent segment weighting. | 139% of target for 2025 for both Joseph LaPlume and Victoria Creamer |
COO Chief Operating Officer during 2025 | 80% of base | Annual Executive Incentive Compensation Plan. | 139% of target for 2025; Birgit Girshick's $620,000 target paid $861,800 |
CFO Executive Vice President and Chief Financial Officer | 85% of base | Annual Executive Incentive Compensation Plan, prorated for 2026 under the February 2026 offer terms. | Not publicly disclosed |
CEO Chief Executive Officer | 100% of base | Annual Executive Incentive Compensation Plan with a 200 percent maximum payout; the same target applies to Birgit Girshick from May 2026. | 139% of target for 2025; James Foster's $1,570,263 target paid $2,182,666 |
Executive incentive targets — percent of salary
Named-executive outcomes
| Executive | Target | Paid | Attainment |
|---|---|---|---|
| James C. Foster | $1,570,263 | $2,182,666 | 139% of target |
| Birgit Girshick | $620,000 | $861,800 | 139% of target |
| Michael G. Knell | $250,000 | $347,500 | 139% of target |
Employee payout timing and history
There is no published employee payout percentage for any year. The proxy describes employees on short-term incentive plans sharing the same global and segment metric architecture, which confirms that non-executive incentive plans exist, but it does not publish a target by band, an eligibility rule, a payout history or a cadence. Monthly, quarterly and semiannual arrangements are not disclosed either; the Executive Incentive Compensation Plan itself is strictly annual.
Sales and special incentives
Charles River runs a commercial ladder from Client Manager through Business Development Director and Senior Business Development Director to Regional Sales Director, and those roles almost certainly carry quota-based variable pay. No quota, commission rate, accelerator, draw or split structure is published in any reviewed source, so no sales incentive is modelled anywhere in this report. Spot bonuses, project incentives and deal bonuses are in the same position: plausible, role-specific and entirely unevidenced.
Equity — RSUs, PSUs, Options & ESPP
Charles River is a New York Stock Exchange issuer, so employee equity means restricted stock units, performance share units, options and an employee stock purchase plan rather than an Indian-style employee stock ownership plan. The active platform changed on 5 May 2026, when shareholders approved the 2026 Long-Term Incentive Plan and new grants under the 2018 plan stopped.
- Share usage, the company's own burn-rate measure, was 1.05 percent in 2023, 0.95 percent in 2024 and 1.34 percent in 2025, for a three-year average of 1.11 percent. The 2025 rise came alongside the restructuring rather than alongside headcount growth.
- Stock-based compensation expense has been remarkably flat: $72.048 million in 2023, $69.891 million in 2024 and $71.083 million in 2025, against a workforce that fell from roughly 21,800 to 19,700 over the same period.
- The 2018 plan's 2,274,083 unused shares were deliberately not carried into the 2026 plan, so the 4,825,000 newly registered shares are the whole current authority rather than an addition to an existing balance.
- At the $297.64 report-date reference share price a $1 million target grant is roughly 3,360 shares before valuation discounts, performance leverage and grant-date price differences. Grant-date fair value in the filings governs, not this illustration.
Equity plan capacity and grant activity
Vesting — common reported employee schedule
Restricted stock units principally vest over four years and executive annual awards commonly vest ratably across that period; options also vest over four years with a ten-year term. Performance share units do not follow this schedule at all. They run a single three-year performance period and settle once, so the four-year table applies to the restricted and option components only. Under the French sub-plan no award may vest before the first anniversary, and if vesting occurs before two years a holding period runs until the second anniversary.
Eligibility by hierarchy level
- The plan permits awards to eligible employees, officers, directors and other service providers, but Charles River publishes no minimum eligible band, no routine grant size below senior leadership and no pool utilisation by grade. Plan eligibility is not evidence that every employee receives stock.
- The public evidence supports exact executive grants, general award mechanics and the existence of a United States employee stock purchase plan. It does not support a conclusion either way about routine grants at B0 to B8, which is why this report shows a real zero in the band table rather than a guess.
- The first band with any public equity marker at all is B10, where a designated Corporate Vice President becomes subject to a 1x base stock-ownership guideline. That is evidence of senior equity participation, not evidence of a minimum grant size.
- Stock-ownership guidelines rise steeply through the officer tier: 1x base at Corporate Vice President, 2x at Senior Vice President, 3x at Corporate Executive Vice President and 6x at Chief Executive Officer.
- Non-employee directors receive equity under the separate director compensation programme, with FY2025 totals generally between $320,708 and $365,859 including cash retainers, subject to a plan cap and holding requirements.
- 2025 performance share units were scored on first-year non-GAAP earnings per share plus three-year relative total shareholder return, paying 0 to 200 percent. The relative return component adjusts the base result by plus or minus 35 percentage points, and a result below 90 percent of the earnings target pays nothing for the whole grant.
Named executive target equity
| Executive | Target | Units / structure |
|---|---|---|
Birgit Girshick Chief Executive Officer from 5 May 2026 | $9.0M initial target fair value | 80 percent performance share units and 20 percent restricted stock units, the most performance-weighted mix disclosed by the company, with eligible retirement treatment and an expected change-in-control agreement providing 3x salary plus target bonus on a qualifying double-trigger termination. |
James C. Foster Chair, President and Chief Executive Officer during FY2025 | $11.601M FY2025 stock awards | Grant-date value reported in the Summary Compensation Table, about 75 percent of his $15,435,220 total. A separate transition grant accompanied the January 2026 chief executive succession announcement. |
Glenn Coleman Executive Vice President and Chief Financial Officer | $3.0M annual award plus $3.5M one-time | The annual award is 60 percent performance share units and 40 percent restricted stock units. The one-time $3,500,000 restricted unit award vests 25 percent a year over four years and sits alongside $1,875,000 of staged new-hire cash. |
Joseph W. LaPlume Corporate Executive Vice President, Corporate Development and Strategy | $2.261M FY2025 stock awards | Annual grant made in the second quarter after the annual meeting; a 5,257-unit restricted award followed on 29 May 2026 at $180.71 a share. |
Victoria L. Creamer Corporate Executive Vice President and Chief People Officer | $2.106M FY2025 stock awards | The lowest corporate executive vice president grant in the FY2025 table. Her August 2026 option exercise at a $179.66 strike shows that legacy option grants from earlier plans are still live in this population. |
Executive Compensation
FY2025 Summary Compensation Table values from the 2026 proxy statement filed 31 March 2026. Equity is a grant-date accounting value rather than cash received, and the table belongs to James Foster's final year as chief executive rather than to the current leadership.
Reading the package
Stock awards were about 75 percent of James Foster's FY2025 reported total and salary about 10 percent, with the cash incentive contributing 14 percent at a 139 percent payout. That is an equity-weighted package by any standard but noticeably less extreme than large-cap technology, where salary can fall below 3 percent of the total. The successor package pushes further in the same direction: Birgit Girshick's $9.0 million initial equity target against a $1.2 million base is 80 percent performance share units, so four fifths of her grant value can settle anywhere between zero and twice target.
This comparison is deliberately narrow, limited to current 2026 proxy disclosures for directly comparable contract-research and life-science issuers. Charles River's own 2025 compensation peer group is far broader at 37 companies spanning contract-research organisations, life-science tools, diagnostics, pharmaceuticals and medical devices, and its consultant regressed the peer data to Charles River's revenue while weighting proxy data 75 percent against survey data 25 percent. Foster's total sits at 1.82 times below IQVIA and about 1.35 times above Medpace and Illumina.
Named Executive Officers & Board
Charles River changed both of its most senior officers inside four months of 2026. Birgit Girshick, previously Chief Operating Officer, became Chief Executive Officer on 5 May 2026 and James Foster moved to a non-executive director seat after decades leading the company. Glenn Coleman became Chief Financial Officer in February 2026, following Michael Knell's interim period and Flavia Pease's departure.
The FY2025 table is a transition-year artefact and should be read as such. Foster's numbers are a full year as chief executive; Girshick's are a full year as chief operating officer, not as chief executive, so her $5,898,392 total understates the role she now holds. Pease appears with $2,409,546 of stock awards but a zero cash incentive, the signature of a departure before the payout date. Knell's row mixes a Senior Vice President base with the workload of an interim Chief Financial Officer. The forward-looking numbers that actually describe the current leadership are in the appointment filings rather than in this table: a $1.2 million chief executive base with a 100 percent target and $9.0 million of initial equity, and an $800,000 chief financial officer base with an 85 percent target, a $3.0 million annual award and $3.5 million of one-time restricted units.
Board compensation framework
| Element | Amount | Notes |
|---|---|---|
| Highest FY2025 director total | $365,859 | Martin Mackay, reflecting additional chair or lead-director responsibilities. |
| Typical full-year director total | $320,708 to $345,859 | Virginia Wilson at $345,859, Paul Graves at $345,708, Nancy Andrews, Reshema Kemps-Polanco and Craig Thompson at $340,859 and George Llado at $325,859. |
| Lowest FY2025 director total | $320,708 | Steven Barg, Abraham Ceesay and Mark Enyedy, the floor of the disclosed range. |
| Structure | Cash retainer plus annual equity | The programme combines cash retainers with an annual equity award; the individual retainer and committee fee schedule was not captured in the reviewed evidence. |
| Ownership and holding rules | Applicable | Directors are subject to the company's stock-ownership and holding requirements and to a cap on total annual director compensation under the plan. |
Ten non-employee directors were disclosed for FY2025 in a tight $320,708 to $365,859 band, a spread of only 14 percent between the highest and lowest paid. Nancy Andrews sold 573 shares on 18 August 2026 at $285.24, the only director open-market transaction in the captured Form 4 window.
Regional heads and other officers
Shannon M. Parisotto, Corporate Executive Vice President for Global Discovery and Safety Assessment, is an active Section 16 filer with two open-market sales in August 2026 but did not qualify as a named executive for FY2025, so no compensation table exists for her. The same is true of every Corporate Vice President and every regional or segment leader: Charles River identifies these leaders in company material but discloses their pay only if an SEC rule forces it. Individual regional-head compensation is therefore not publicly disclosed.
Insider Trades — SEC Forms 3/4/5
Charles River is a New York Stock Exchange-listed Delaware corporation, so the governing record is SEC Section 16 Forms 3, 4 and 5 rather than any Indian exchange filing. Indian SEBI takeover and promoter-group concepts do not apply, and no separate employee stock ownership trust or promoter allotment exists. A Form 4 disposal is not automatically a bearish discretionary sale: an award code marks a grant or a vesting, a withholding code marks shares surrendered to cover tax, and a gift code often marks an estate-planning transfer with no change in beneficial ownership.
| Date | Person | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-19 | Shannon M. Parisotto Corporate Executive Vice President, Global Discovery and Safety Assessment | Sale Open-market sale under a Rule 10b5-1 plan; accession 0001100682-26-000136. | 2,039 | $294.12 | $600K |
| 2026-08-18 | Nancy C. Andrews Non-employee director | Sale Open-market sale; the only director transaction in the captured window. Accession 0001100682-26-000134. | 573 | $285.24 | $163K |
| 2026-08-10 | Joseph W. LaPlume Corporate Executive Vice President, Corporate Development and Strategy | Gift Gift or transfer at no stated price; accession 0001100682-26-000128. | 257 | — | $0 |
| 2026-08-06 | Victoria L. Creamer Corporate Executive Vice President and Chief People Officer | Exercise Option exercise at a $179.66 strike with a same-day sale; accession 0001100682-26-000122. | 4,179 | $259.16 | $1.08M |
| 2026-08-05 | Shannon M. Parisotto Corporate Executive Vice President, Global Discovery and Safety Assessment | Sale Open-market sale under a Rule 10b5-1 plan; accession 0001100682-26-000120. | 5,046 | $263.00 | $1.33M |
| 2026-06-29 | James C. Foster Non-executive director; former Chair, President and Chief Executive Officer | Sale The largest transaction in the window, made under a Rule 10b5-1 plan seven weeks after handing over the chief executive role. Accession 0001100682-26-000111. | 75,000 | $225.00 | $16.88M |
| 2026-06-05 | Birgit Girshick Chief Executive Officer | Gift Transfer to a revocable trust with no change in beneficial ownership; accession 0001100682-26-000107. | 3,386 | — | $0 |
| 2026-05-29 | Glenn Coleman Executive Vice President and Chief Financial Officer | Award Restricted stock unit grant, part of the annual second-quarter grant cycle. Accession 0001100682-26-000101. | 6,640 | $180.71 | $1.20M |
| 2026-05-29 | Joseph W. LaPlume Corporate Executive Vice President, Corporate Development and Strategy | Award Restricted stock unit grant on the same annual grant date, with tax withholding reported on later dates. Accession 0001100682-26-000097. | 5,257 | $180.71 | $950K |
| 2026-05-26 | Victoria L. Creamer Corporate Executive Vice President and Chief People Officer | Withholding Shares withheld to cover tax on a vesting; accession 0001100682-26-000085. | 346 | $158.52 | $55K |
| 2026-01-30 | James C. Foster Chair, President and Chief Executive Officer at the transaction date | Settlement Performance share unit vesting with shares withheld for taxes, the largest settlement in the window. Accession 0001100682-26-000012. | 39,031 | $211.68 | $8.26M |
Reading guide
Benefits & Perks
Charles River publishes benefits at category level rather than as a quantified package, and it does so almost exclusively for the United States. Outside North America the company-specific evidence effectively runs out, so the rows below separate what Charles River actually says from the statutory baseline an employee would fall back on.
United States
- Retirement — 401(k) with a company match. Substantially all United States employees are eligible on employment and the 2025 company plan cost was $26.9 million. The match formula is not published: an executive offer referenced 3 percent while employee reports commonly cite 4 percent, so no universal percentage is asserted here. [official]
- Medical — Medical, dental and vision cover with flexible spending accounts. Confirmed by the company benefits pages at category level. Carriers, deductibles, coverage tiers and the employer share of premium are not publicly disclosed. [official]
- Protection — Life and accidental death cover, short- and long-term disability, critical illness options. Listed on the benefits pages. Multiples of salary, benefit caps and elimination periods are not published. [official]
- Leave — Paid time off, holidays and volunteer time. A current job posting confirms all three categories. Entitlement by tenure and site is not published; employee reports citing 15 paid days plus separate sick or flexible days are anecdotal. [official]
- Growth — Tuition reimbursement and career development. Public benefits pages confirm reimbursement and structured development. Annual caps, approval rules and any repayment clawback on early departure vary and are not published. [official]
- Equity — Employee stock purchase plan. Confirmed to exist for United States employees by the benefits pages and the insider-trading policy. The discount, lookback, offering period and remaining capacity were not verified in any reviewed document. [official]
- Support — Employee assistance programme, employee assistance fund, legal services and discounts. Described publicly at category level alongside recognition and referral programmes. No provider, benefit limit or eligibility rule is published. [official]
Global programs
- Growth — Professional development and career development programmes. Described in global careers material at category level. Specific vendors such as LinkedIn Learning, Udemy or Coursera were not verified in any reviewed source. [official]
- Wellbeing — Employee assistance and wellbeing programmes. Referenced globally in careers material. Session limits, providers and dependant eligibility are not published. [official]
- Community — 11 employee resource groups with roughly 3,000 members. The single hardest global engagement figure the company publishes, equivalent to about 15 percent of the workforce participating in at least one group. [official]
- Recognition — Recognition and referral programmes. Confirmed at category level for the United States. Award values, referral bonus amounts and eligibility rules are not published. [official]
- Mobility — Sabbatical policy and global remote-work entitlement. No formal sabbatical policy and no global remote or hybrid working entitlement was verified in any reviewed source. [npd]
Benefit fields not publicly quantified
Charles River's benefit disclosure is asymmetric in the same way its pay disclosure is. The United States rows come from company benefits pages and job postings; almost everything else in this table is a government rule that sets the floor, not a description of what Charles River actually provides. The company's own defined-contribution plan cost of $26.9 million for 2025 is the only quantified benefit figure in the filings. Treat any international row marked as a statutory baseline as the minimum an employer must do, and confirm the actual package in the offer documents.
Performance Review & Pay Progression
Charles River publishes no performance framework. There is no public rating scale, no calibration or distribution policy, no global review calendar for employees and no merit matrix. What is disclosed is the executive calendar, because SEC rules force it: 2025 base salaries were approved on 20 May 2025 and took effect on 29 June 2025, and annual equity awards are generally granted in the second quarter shortly after the annual meeting.
Not publicly disclosed
Modeled promotion planning timeline
| Band | Years to next scope | Promotion hike | Status |
|---|---|---|---|
| B0 | 0.5–1.5 years to B1 | Not disclosed | Modeled planning interval |
| B1 | 1–2 years to B2 | Not disclosed | Modeled planning interval |
| B2 | 1–3 years to B3 | Not disclosed | Modeled planning interval |
| B3 | 2–4 years to B4 | Not disclosed | Modeled planning interval |
| B4 | 2–4 years to B5 | Not disclosed | Modeled planning interval |
| B5 | 2–5 years to B6 or B7 | Not disclosed | Modeled planning interval |
| B6 | 2–4 years to B7 | Not disclosed | Modeled planning interval |
| B7 | 2–4 years to B8 | Not disclosed | Modeled planning interval |
| B8 | 2–5 years to B9 | Not disclosed | Modeled planning interval |
| B9 | 3–6 years to B10 | Not disclosed | Modeled planning interval |
| B10 | Selection-based; the move to the officer tier resets the package | Not disclosed | Modeled planning interval |
The one part of the calendar with real visibility is the executive cycle: salary actions approved in May and effective at the end of June, with annual equity granted in the second quarter after the annual meeting. The 29 May 2026 restricted stock unit grants to Glenn Coleman and Joseph LaPlume at $180.71 a share are that cycle in the Form 4 record. Nothing equivalent is published for the employee population, and no market-correction or off-cycle adjustment schedule was found, so any local adjustment should be confirmed with the hiring manager or in the offer letter.
Pay progression evidence
Modelled progression, not Charles River policy: B0 to B1 typically takes 0.5 to 1.5 years for a 5 to 12 percent increase; B1 to B2 takes 1 to 2 years for 6 to 12 percent; B2 to B3 takes 1 to 3 years for 8 to 15 percent; B3 to B4 takes 2 to 4 years for 8 to 18 percent; B4 to B5 takes 2 to 4 years for 8 to 18 percent; B5 to B6 or B7 takes 2 to 5 years for 10 to 20 percent depending on whether the path is expert or management; B7 to B8 takes 2 to 4 years for 10 to 20 percent; B8 to B9 takes 2 to 5 years for 12 to 25 percent; and B9 to B10 takes 3 to 6 years for 15 to 30 percent. The move from B10 into the officer tier is selection-based and resets the package entirely rather than applying a percentage. Within a job family the numbered rungs move faster than these band transitions, because Animal Technician I to II or Research Scientist I to II is a step inside a band rather than a step across one.
H-1B / LCA Visa Footprint — United States
Charles River is a light and inconsistent H-1B sponsor by technology-company standards, and the public aggregators disagree with each other about even the basic FY2025 count. Labour condition application wages are a role and location wage commitment in base salary terms, not total compensation, and they are not a payroll census or an approval record.
Dataset summary
| Dataset | Result | Interpretation |
|---|---|---|
| h1bdata.info FY2025 | 37 records at a $113,740 median | 5 percent of records above $200,000 and 16 percent between $150,000 and $200,000. A snapshot by that aggregator's extraction. |
| Ellis FY2025 | 39 labour condition applications at a $110,000 median | A different extraction of the same underlying Department of Labor disclosure data, two records higher and $3,740 lower on the median. |
| H1BGrader FY2025 | $133,179 median with a $275,525 maximum | The highest median of the four, with no record count shown in the captured result, so the denominator cannot be checked. |
| MyVisaJobs FY2025 | $131,471 average proffered wage | An average rather than a median, against a $124,916 average prevailing wage, so the premium over prevailing wage is about 5 percent. |
| Ellis FY2021–FY2026 history | 151 certified filings at $91,000 / $126,000 / $159,000 | The only captured source with a full quartile distribution, and the basis for the single city row below. |
City-level H-1B wage history
| City | P25 | Median | P75 | Records |
|---|---|---|---|---|
United States, all worksites Certified filings FY2021 to FY2026, the only captured distribution with quartiles | $91K | $126,000 | $159K | 151 |
All-years aggregates. P25/P75 are rounded reconstruction values marked modeled; medians and record counts are the stronger fields.
Selected title / worksite records
| Title | Worksite | Proffered wage | Notes |
|---|---|---|---|
| Site concentration | Mattawan, Michigan | $76,594 median across 30 records | The largest single worksite in the captured location data. 87 percent of its records sit below $100,000, consistent with scientific and support titles at a lower-cost site rather than with a senior technical mix. |
| Senior Data Engineer | Nolensville, Tennessee | $160,000 median across 2 records | The highest captured worksite median and a two-record sample, so it describes a specific hire rather than a site pay level. |
| Scientist 2 | United States, captured dataset | $108,150 median across 2 records | A title-specific sample too small to compare against the B4 or B5 band medians with any confidence. |
| Formulations Specialist | Horsham, Pennsylvania | $76,003 | A single certified filing, included because it is the only Pennsylvania anchor in the visa record. |
| Prevailing wage level mix | United States, FY2021 to FY2026 | $84,000 / $105,000 / $120,000 / $153,000 | Department of Labor wage levels I to IV with 29, 55, 7 and 60 filings respectively. The distribution is barbelled: level II and level IV together carry 76 percent of filings while level III carries only 5 percent. |
Reading the data correctly
- A labour condition application is a wage commitment for a role at a worksite, not a payroll record, a total compensation figure or an approved petition. It excludes any bonus and any equity.
- Only one row in the city table carries quartiles, because the captured aggregators publish a median without a distribution for every individual worksite. Mattawan, Nolensville and the title-level anchors are therefore shown as examples rather than as distributions.
- The four FY2025 aggregators disagree on both count and median by wide margins. Any single figure quoted from one of them without naming the source is unreliable.
- No reconciled company-level USCIS approval rate exists in any reviewed source, and the underlying research file deliberately stores that field as null rather than inserting an unsupported percentage.
- The visa population is a small and skewed slice of a 19,700-person workforce concentrated in laboratory operations, so it should not be read as representative of Charles River pay generally.
Key Nuances & Insights
Research Scientist I to VII, Animal Technician I to IV and Biomanufacturing Technician I to III give real progression clues inside a function, but they number independently and none of them is a company-wide grade. Anyone converting a title into a corporate grade without internal human-resources data is inventing structure that Charles River has never published.
No employee bonus target and no employee grant size is disclosed at any band below the officer tier. The honest total for B0 to B10 is therefore base pay. The underlying research file computed a total by applying a notional employer-cost uplift rising from 1.06 times at B0 to 1.8 times at B10; that is what an employee costs, not what an employee is paid, and it has been stripped here.
Several United States Research Scientist I postings asked for around six years of experience, which is why the title maps to B4 rather than to the bottom of the ladder. The Roman numeral marks a rung inside a scientific family that starts above the technician ladder, not the first job in the company.
The same Research Scientist I title was posted at $87,000 to $93,000 in Ashland, Ohio, from $95,000 in Reno and $100,000 to $110,000 in Shrewsbury, Massachusetts. That is a 15 percent spread on an identical title inside one country, and Mattawan's captured visa median of $76,594 sits lower again. Negotiating the site is a real lever.
Every named executive was paid at exactly 139 percent of target for 2025 and the committee applied no discretionary adjustment. The Executive Incentive Compensation Plan is a formula on global and segment revenue and operating income, not a judgement call, so an individual performance rating does not move the executive cash number.
Nothing funds below 85 percent of target performance, and for 2025 performance share units a result below 90 percent of the earnings-per-share target pays zero for the entire grant rather than a reduced amount. The relative total shareholder return modifier then moves the base result by plus or minus 35 percentage points on top of that.
New grants under the 2018 plan stopped on 5 May 2026 and its 2,274,083 unused shares were deliberately not carried forward. Anyone holding a 2024 or 2025 award keeps their original terms; anyone joining after May 2026 is on the new 4,825,000-share plan, where a restricted or performance unit consumes two pool units against one for an option.
Charles River disclosed 68 employees in India in the FY2025 pay-ratio population, alongside 42 in South Korea, 41 in Singapore, 18 in Australia and two in Israel. Applying information-technology-services concepts such as offshore band structures or onsite allowances to this footprint would misstate the operating model entirely.
Because equity is not evidenced below the officer tier, there is no senior stock component to narrow the international gap at the top of the ladder. A Tranent scientist sits at roughly half the Wilmington median at both junior and senior bands, where a comparable technology company would show the offshore ratio climbing sharply with seniority.
Headcount fell about 8 percent in 2024 and about 2 percent more in 2025, 15 smaller sites were closed, the Hanover cell-therapy site shut in February 2026 and European discovery assets and the cell-solutions business were divested. Every one of those changes moves the employee mix, the median pay figure and the local sample sizes behind these bands.
The $15,435,220 headline belongs to James Foster's final full year. Birgit Girshick's own terms are forward-looking appointment figures, a $1.2 million base, a 100 percent target and a $9.0 million initial equity target, and no FY2026 Summary Compensation Table exists for her yet. The next proxy will change the headline number materially.
Four aggregators report FY2025 medians between $110,000 and $133,179 on counts between 37 and 39 records. A labour condition application is a base-salary commitment for a role at a worksite, excludes bonus and equity, and says nothing about whether the petition was approved.
No Charles River dataset publicly separates lateral hires from internal promotees at the same level. Glenn Coleman's $1,875,000 of staged new-hire cash and $3,500,000 one-time restricted units show what an external senior hire can command, but that is an officer appointment and generalising it downward would be speculation.
Research control
Against directly comparable 2026 proxy disclosures James Foster's $15,435,220 sat 1.82 times below IQVIA's Ari Bousbib and about 1.35 times above Medpace and Illumina, placing Charles River second of four. The 251:1 pay ratio is high for the sector, but the driver is the denominator rather than the numerator: a $61,430 global median employee reflects a laboratory, animal-care and manufacturing workforce spread across more than 120 sites, not a professional-services population. On the employee side the United States scientific ladder from Associate Scientist to Senior Director tracks the contract-research market closely, while the absence of any disclosed employee bonus or equity means a Charles River package is more cash-dominated than a comparable role at a life-science tools company.
Evidence classification
| Label | Meaning | Examples and permitted use |
|---|---|---|
| Verified | A Charles River SEC filing, an official company benefits or careers page, a company job posting with a disclosed pay range, or a government rule. | Executive and director compensation, the pay ratio, equity plan terms and share counts, incentive plan mechanics, headcount, turnover, revenue and the United States band anchors. |
| Reported | A named third-party dataset with observable records, chiefly Glassdoor, Levels.fyi, Indeed, PayScale, Comparably and the visa aggregators. | The United Kingdom, Australian, Canadian, French and Indian title observations and the whole H-1B wage distribution. |
| Modeled | The Wilmington anchor median multiplied by a single city calibration factor and the 26 August 2026 foreign-exchange snapshot, inside a plus or minus 15 percent planning envelope. | Every non-United States cell, plus the B0, B6 and B10 anchors where no company posting disclosed a range. |
| Not publicly disclosed | No source in the research bundle supports a figure. | Recorded as such rather than estimated, most visibly for employee bonus targets, employee equity grants and the employee stock purchase plan terms. |
Explicit “Not publicly disclosed” index
Known gaps and diligence before relying on a cell
- 1Only one research bundle exists for Charles River, so no cross-bundle disagreement had to be resolved. The trade-off is that every figure rests on a single research pass and no second extraction was available to check it against.
- 2The officer and chief executive rows are deliberately excluded from the band table. Their pay is a global peer-market figure that appears identically in every city table in the source material, and applying a 0.16 India factor or a 0.50 United Kingdom factor to a $1.2 million chief executive base would manufacture a local executive scale that does not exist. Those figures are carried in the executive section instead, and the employee ladder runs B0 to B10 at seniority 1 to 11.
- 3The source model computed total compensation as base multiplied by a notional employer-cost uplift running from 1.06 times at B0 to 1.8 times at B10. That is employer cost rather than pay, so it has been removed and total has been rebuilt from components, which makes total equal base for every band.
- 4City calibration factors are the bundle's own planning multipliers rather than observed ratios in most markets. Only Shrewsbury, Reno, Mattawan, Tranent, Montréal, Lyon, Melbourne and Bangalore have any direct local observation behind them, and Bangalore's rests on a two-profile reported average.
- 5Base and total factors are identical and flat across the ladder, and no top-of-ladder factor is applied, because the source model evidences no level-dependent geographic compression for this operating model. If Charles River does grant equity below the officer tier, the real international ratios would widen at senior bands and these factors would understate them.
- 6The four H-1B aggregators cannot be merged. FY2025 counts run 37 against 39 and medians run $110,000 against $113,740 against $133,179, and no captured source publishes a reconciled USCIS approval rate, so none is stated.
- 7The 2023 headcount of roughly 21,800 is inferred from the disclosed 2024 percentage decline rather than separately disclosed, and is labelled as such in the workforce table.
- 8The employee stock purchase plan is confirmed to exist but none of its economics were verified, so no purchase discount value appears anywhere in this report.
- 9No company-wide 2026 salary increase percentage, pay freeze, salary cut, campus offer revision or off-cycle correction was located in any reviewed source.
FX rates used — 1 USD equals, snapshot 2026-08-26
Single-date conversion layer for comparability; it ignores payroll-date FX, tax, purchasing power, benefits valuation and hedging. Compensation intelligence, not legal, tax, investment, immigration or employment advice.
Source register — 19 sources
| DEF 14A 2026 | Charles River Laboratories 2026 Proxy Statement, accession 0001104659-26-037367 · United States Securities and Exchange Commission · 2026-03-31. Executive and director compensation, the Executive Incentive Compensation Plan, the equity plan proposal, the pay ratio, stock-ownership guidelines, share usage rates and the compensation peer group. |
| 10-K FY2025 | Form 10-K for the year ended 27 December 2025, accession 0001100682-26-000022 · United States Securities and Exchange Commission · 2026-02-18. Headcount, voluntary turnover, revenue, the geographic and segment workforce split, benefit plan cost, stock-based compensation expense and restructuring. |
| 10-Q Q2 2026 | Form 10-Q for the quarter ended 27 June 2026, accession 0001100682-26-000118 · United States Securities and Exchange Commission · 2026-08-06. Second-quarter revenue, backlog, restructuring progress, repurchases and portfolio changes. |
| 8-K CEO | Chief executive transition Form 8-K, accession 0001628280-26-001603 · United States Securities and Exchange Commission · 2026-01-08. Birgit Girshick's appointment terms and James Foster's transition grant. |
| 8-K CFO | Chief financial officer appointment Form 8-K, accession 0000950103-26-002326 · United States Securities and Exchange Commission · 2026-02-18. Glenn Coleman's base, target bonus, annual equity, staged new-hire cash and one-time restricted stock unit award. |
| 2026 LTIP | Charles River 2026 Long-Term Incentive Plan, accession 0000950103-26-007060 · United States Securities and Exchange Commission · 2026-05-05. Plan authority, eligible award types, fungible-share ratio, minimum vesting, prohibited practices and the French sub-plan. |
| S-8 2026 | Form S-8 registration for the 2026 Long-Term Incentive Plan, accession 0000950103-26-006962 · United States Securities and Exchange Commission · 2026-05-31. Registration of 4,825,000 shares under the new plan. |
| Forms 4 | Charles River Section 16 Forms 4 filed January to August 2026 · United States Securities and Exchange Commission · 2026-08-19. Grants, performance unit vesting, tax withholding, estate-planning transfers, option exercises and open-market sales. |
| Careers | Charles River careers role-family pages and job postings with disclosed United States ranges · Charles River Laboratories · 2026-08-26. Job-family ladders, titles, benefit categories and every United States band anchor from Animal Research Technician I to Senior Director. |
| Locations | Charles River global locations directory · Charles River Laboratories · 2026-08-26. Confirmation that every city in this report is an official Charles River location. |
| Glassdoor | Glassdoor Charles River salary records for the United States, United Kingdom and Australia · Glassdoor · 2026-08-26. United Kingdom Scientist, Senior Scientist and Study Director ranges and a four-salary Australian sample used only as low-confidence anchors. |
| Levels.fyi | Levels.fyi Charles River compensation records · Levels.fyi · 2026-08-26. Cross-functional United States total compensation medians and ranges. |
| Indeed | Indeed salary pages and company job mirrors · Indeed · 2026-08-26. United States, United Kingdom, Canadian and French salary observations including the Lyon Study Director average. |
| PayScale | PayScale Research Scientist at Charles River Laboratories · PayScale · 2026-08-26. Research Scientist range and average used to check the B4 anchor. |
| Comparably | Comparably Charles River Laboratories compensation · Comparably · 2026-08-26. Modelled company-wide salary and bonus estimates, used only as a cross-check and never as a payroll record. |
| H-1B extracts | h1bdata.info, H1BGrader, MyVisaJobs and Ellis Charles River extracts · Third-party Department of Labor aggregators · 2026-08-26. FY2025 and cross-year wage distributions, worksite medians, title anchors and prevailing wage level mix. |
| Statutory baselines | EPFO, India Ministry of Labour, Australian Taxation Office, Fair Work Ombudsman, UK Government pensions and leave guidance, Government of Canada labour standards · National governments and statutory agencies · 2026-08-26. The Provident Fund, gratuity, maternity, superannuation, leave, auto-enrolment pension and vacation floors quoted in the benefits table. |
| Peer proxies | IQVIA, Medpace and Illumina 2026 proxy statements · United States Securities and Exchange Commission · 2026-03-16. Peer chief executive compensation comparison. |
| FX snapshot | Public mid-market foreign-exchange references · Public mid-market rate sources · 2026-08-26. Every local currency conversion in this report; informational rates rather than transaction rates. |
Recent News & Workforce Trend
Charles River's 2026 has been a governance and restructuring year rather than a pay year. Both top officers changed, the equity platform was replaced, two businesses were divested and no company-wide salary action was announced in any reviewed source.
The workforce shrank about 10 percent across two years while stock-based compensation expense stayed flat between $69.9 million and $72.0 million, so equity spend per remaining employee rose even though no new employee grant programme was announced. Voluntary turnover falling from 11.1 to 10.1 percent alongside site closures is a mixed signal: fewer people are leaving by choice, but the population they are leaving is smaller and has already absorbed involuntary reductions. Median employee compensation for FY2025 was $61,430, and comparable prior-year medians should be read from each proxy's own methodology rather than treated as a series, because the population and the selection change year to year.
Second-quarter revenue was $1.004 billion. Management maintained a 2026 focus on operating execution while the divestitures reduced the reported growth base.
The new plan registered 4,825,000 shares and ended new grants under the 2018 plan, whose 2,274,083 remaining shares did not roll over.
Her terms are a $1.2 million base, a 100 percent target annual cash incentive and a $9.0 million initial equity target split 80 percent performance share units and 20 percent restricted stock units. James Foster moved to a non-executive director seat.
James Foster's FY2025 total was $15,435,220 against a $61,430 median employee identified from 19,878 employees as of 1 November 2025. Every named executive was paid at 139 percent of target with no discretionary adjustment.
Certain European discovery assets were sold to IQVIA and the contract development and manufacturing cell-solutions business to GI Partners, reshaping the revenue and margin profile and moving affected employees out of the Charles River population.
Offer terms are an $800,000 base, an 85 percent target bonus, a $3.0 million annual equity award split 60 percent performance and 40 percent restricted units, $1,875,000 of staged new-hire cash and a $3,500,000 one-time restricted unit award vesting over four years.
Approximately 19,700 employees at 27 December 2025, voluntary turnover of 10.1 percent, revenue of $4.015 billion, stock-based compensation of $71.083 million and a United States defined-contribution plan cost of $26.9 million.
The closure followed earlier Wilmington reductions and continued the contraction of the manufacturing footprint that began in 2024.
James Foster's completed three-year performance cycle settled at a $211.68 reference price for $8.26 million gross, with shares withheld for taxes. It is the largest settlement in the captured Form 4 window.
The Form 8-K set out Birgit Girshick's appointment and compensation terms and James Foster's transition grant, four months before the change took effect at the annual meeting.
Charles River closed FY2025 with approximately 19,700 employees and 10.1 percent voluntary turnover, against roughly 20,100 and 11.1 percent a year earlier.
Reporting described the closure of 15 smaller sites and a planned workforce reduction of roughly 3 percent, part of a programme management expected to reach about $300 million of cumulative annualised cost savings by the end of 2026.